Skip to main content
. 2020 Jun 30;24(15):8326–8349. doi: 10.1111/jcmm.15097

Table 3.

Effects of clinical parameters and hemograms on the arrest of bone marrow and radiodermatitis in NPC patients (n = 507)

Variables n Arrest of bone marrow Radiodermatitis
OR 95% CI P OR 95% CI P
Sex 1.428 0.845‐2.412 .183 1.234 0.767‐1.986 .385
Male 386 Ref. Ref.
Female 121
Age 1.289 0.777‐2.138 .325 0.669 0.433‐1.034 .070
<60 389 Ref. Ref.
≥60 118
T .387 .735
T1 62 Ref. Ref.
T2 149 0.828 0.400‐1.720 .613 1.220 0.629‐2.366 .556
T3 151 1.227 0.590‐2.549 .584 1.218 0.619‐2.395 .568
T4 145 0.785 0.375‐1.644 .521 0.962 0.489‐1.892 .910
N .100 .950
N0 40 Ref. Ref.
N1 84 0.434 0.183‐1.030 .058 0.817 0.357‐1.866 .631
N2 305 0.494 0.231‐1.059 .070 0.915 0.436‐1.923 .815
N3 78 0.317 0.126‐0.797 .015 0.834 0.351‐1.984 .681
M 1.277 0.670‐2.432 .457 1.635 0.927‐2.885 .090
M0 436 Ref. Ref.
M1 71
Histology .142 .495
Keratinizing* 12 Ref. Ref.
Non‐Keratinizing# 479 0.361 0.099‐1.319 .123 0.414 0.097‐1.777 .235
Unknown 16 0.763 0.141‐4.111 .753 0.417 0.070‐2.492 .337
SIRI 1.219 0.615‐2.414 .571 0.852 0.452‐1.606 .621
<1.529 367 Ref. Ref.
≥1.529 140
NLR 0.922 0.411‐2.068 .844 1.179 0.553‐2.511 .670
<3.441 377 Ref. Ref.
≥3.441 130
SII 0.935 0.432‐2.025 .865 1.069 0.505‐2.263 .861
<715.739 384 Ref. Ref.
≥715.739 123
PLR 1.776 0.903‐3.492 .096 1.158 0.518‐2.589 .720
<245.496 442 Ref. Ref.
≥245.496 65
WBC .049 .850
Normal 341 Ref. Ref.
Low 146 0.531 0.319‐0.885 .015 1.229 0.593‐2.548 .579
High 20 1.038 0.366‐2.945 .944 0.853 0.132‐5.489 .867
RBC .390 .335
Normal 324 Ref. Ref.
Low 178 1.223 0.621‐2.408 .560 1.510 0.832‐2.740 .176
High 5 5.164 0.399‐66.905 .209 0.464 0.044‐4.942 .525
HGB 0.618 0.319‐1.198 .154 0.687 0.382‐1.236 .210
Normal 330 Ref. Ref.
Low 177
PLT .476 .370
Normal 455 Ref. Ref.
Low 15 1.008 0.225‐4.520 .992 1.501 0.420‐5.362 .532
High 37 1.690 0.727‐3.932 .223 1.787 0.735‐4.346 .200
NEU .591 .268
Normal 370 Ref. Ref.
Low 109 0.834 0.380‐1.832 .652 0.557 0.270‐1.148 .112
High 28 0.468 0.091‐2.414 .364 0.769 0.145‐4.089 .758
LYM .001 .022
Normal 379 Ref. Ref.
Low 127 2.939 1.655‐5.218 .000 1.878 1.202‐2.936 .006
High 1 7.951E+09 0‐ .999 0.000 0‐ .999
MONO 1.561 0.682‐3.577 0.292 1.063 0.502‐2.248 .873
Normal 463 Ref. Ref.
High 44
EO .000 .002
Normal 210 Ref. Ref.
Low 290 0.343 0.227‐0.519 .000 0.502 0.342‐0.736 .000
High 7 0.297 0.049‐1.787 .185 1.122 0.206‐6.107 .894
BASO 0.646 0.156‐2.668 .546 0.252 0.062‐1.021 .053
Normal 497 Ref. Ref.
High 10
HCT 0.489 0.317‐0.754 .001 0.861 0.524‐1.412 .553
Normal 154 Ref. Ref.
Low 353
MCV .002 .954
Normal 483 Ref. Ref.
Low 13 6.694 2.002‐22.377 .002 0.922 0.055‐15.414 .955
High 11 3.154 0.831‐11.974 .091 1.277 0.262‐6.217 .762
MCH .487 .350
Normal 485 Ref. Ref.
Low 12 0.325 0.020‐5.256 .428 4.112 0.173‐97.498 .381
High 10 2.246 0.390‐12.924 .365 2.934 0.466‐18.493 .252
MCHC .545 .619
Normal 481 Ref. Ref.
Low 23 1.754 0.565‐5.441 .331 1.744 0.573‐5.309 .327
High 3 0.454 0.024‐8.660 .600 0.971 0.059‐15.998 .984
RDW 0.974 0.475‐1.997 .943 0.849 0.456‐1.581 .606
Normal 436 Ref. Ref.
High 71
MPV 1.190 0.024‐59.676 .931 0.484 0.018‐12.830 .665
Normal 505 Ref. Ref.
High 2

Keratinizing squamous cell carcinoma; non‐keratinizing carcinoma.